Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The miraDry system uses microwave/thermal energy to permanently eliminate sweat and odor glands as well as hair follicles in the underarms. It has FDA clearance for primary axillary hyperhidrosis, odor reduction, and permanent underarm hair removal. Clinical studies report an average of ~82% sweat reduction at one year post-treatment with lasting results; most patients require only one or two treatments. Over 360,000 procedures have been performed globally.
The treatment has demonstrated high efficacy and safety with minimal downtime. It remains the only FDA-cleared non-surgical permanent solution for these indications.
Not cleared for use on hands or feet.
The company has received multiple industry awards for innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on miraDry.